Valuation: Safeguard Scientifics, Inc.

Market Cap 14.42M 12.92M 11.93M 10.82M 20.16M 1.37B 20.44M 143M 56.89M 718M 54.08M 52.95M 2.27B P/E 2022
-3.55x
P/E 2023 -1.29x
Enterprise Value 6.17M 5.53M 5.1M 4.63M 8.62M 587M 8.74M 61.08M 24.33M 307M 23.13M 22.65M 973M EV / Sales 2022
-
EV / Sales 2023 -
Free-Float
77.17%
Yield 2022 *
-
Yield 2023 -
1 day+13.98%
1 week-3.92%
Current month-2.00%
1 month+19.51%
3 months+25.64%
6 months+22.50%
Current year-39.13%
1 week 0.49
Extreme 0.49
0.53
1 month 0.45
Extreme 0.45
0.53
Current year 0.22
Extreme 0.22
1.89
1 year 0.22
Extreme 0.22
1.89
3 years 0.22
Extreme 0.22
1.89
5 years 0.22
Extreme 0.22
8.72
10 years 0.22
Extreme 0.22
14.4
Manager TitleAgeSince
Chief Executive Officer 59 01/01/2024
Director TitleAgeSince
Chairman 60 25/05/2022
Director/Board Member 53 25/05/2022
Date Insider Type Main position Quantity % Market Cap. Importance
30/1/24 Free

Chairman

38,087 0.1149%
30/1/24 Free

Director

20,775 0.0627%
30/1/24
Kenneth Rainin Foundation
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
+13.98%-3.92%-44.70%-51.49% 8.7M
+1.92%+0.72%+2.93%+93.60% 176B
-0.62%-1.28%+25.57%+81.99% 143B
+0.68%+1.88%+37.01%+256.93% 99.31B
+0.31%+6.84%-22.83%+30.63% 93.33B
+0.71%+2.51%-17.76%+99.64% 84.92B
+1.22%+3.53%-22.86%+71.98% 82.51B
+0.87%+2.68%-13.23%+64.97% 74.75B
-0.10%+2.30%-8.20%+42.20% 67.48B
+1.55%+2.72%+46.23%+175.77% 46.62B
Average +2.05%+1.96%-1.78%+86.62% 86.81B
Weighted average by Cap. +0.73%+1.84%+3.39%+100.08%

Financials

2022 2023
Net sales - -
Net income -14.26M -12.78M -11.8M -10.7M -19.95M -1.36B -20.22M -141M -56.29M -711M -53.51M -52.39M -2.25B -9.83M -8.81M -8.13M -7.37M -13.74M -936M -13.94M -97.35M -38.78M -490M -36.87M -36.1M -1.55B
Net Debt -18.47M -16.55M -15.28M -13.86M -25.83M -1.76B -26.19M -183M -72.89M -920M -69.28M -67.83M -2.91B -8.25M -7.39M -6.83M -6.19M -11.54M -785M -11.7M -81.71M -32.55M -411M -30.95M -30.3M -1.3B
Projected Income Statement - Annual - Safeguard Scientifics, Inc.
Logo Safeguard Scientifics, Inc.
Safeguard Scientifics, Inc. is a provider of capital and relevant expertise to technology-driven businesses. The Company offers strategic, operational and management support to certain of its ownership interests, which include defining short and long-term strategic goals; identifying and planning for the critical success factors to reach these goals; identifying and addressing the challenges and operational improvements required to achieve the critical success factors and, ultimately, the strategic goals; identifying and implementing the business measurements that the Company and others are apply to measure a company’s success; and identifying sources of and providing capital to drive growth. It also continues to hold relatively small equity interests in other enterprises where it does not exert significant influence and do not participate in management activities. The Company's subsidiaries include Bonfield VII, Ltd., Safeguard Delaware, Inc., SFE Properties, Inc., and others.
Employees
33
Date Price Change Volume
28/10/26 USD 0.5349 +2.87% 2,928
26/10/26 USD 0.5200 -1.87% 36,059
23/10/26 USD 0.5299 +5.98% 55,368
22/10/26 USD 0.5000 -1.96% 15,050
21/10/26 USD 0.5100 -.--% 5,000
  1. Stock Market
  2. Stocks
  3. SFES Stock